We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Autologous Fat Harvester Facilitates Plastic Surgery

By HospiMedica International staff writers
Posted on 12 Dec 2017
Print article
Image: The LipoGrafter set, including K-VAC Syringe, AT-Valve, and collection bag (Photo courtesy of MTF Biologics).
Image: The LipoGrafter set, including K-VAC Syringe, AT-Valve, and collection bag (Photo courtesy of MTF Biologics).
A large-volume fat grafting solution offers plastic surgeons a convenient, closed system for harvesting and depositing autologous fat.

The MTF Biologics (Edison, NJ, USA) LipoGrafter is an efficient, self-contained system for the atraumatic and low pressure, harvesting, processing, and grafting of human lipoaspirate. The system includes the K-VAC Syringe, which delivers constant, spring-activated 300 mmHg harvesting pressure; an atraumatic tissue valve (AT-Valve) for automatically transferring the lipoaspirate to the containment vessel without clogging; and tubing and bags for its collection, processing, and re-injection.

Following collection of the autologous fat, gravity sedimentation is used to concentrate it in collection bags by hanging them an IV pole, using sterile endotracheal tube stylet as hooks. The AT-Valve is then used to transfer the aspirate directly from the bag to the patient by switching it from harvesting mode to grafting mode, providing efficient micrografting of 0.1 ml /cm per pass, without switching between syringes and cannulas. Each sterile, single-use LipoGrafter disposable kit contains a KVAC syringe, four collection bags, the multi-port AT-Valve and a sterile tubing set with connectors.

“MTF Biologics is dedicated to offering surgeons innovative technologies and solutions that help them better serve their patients," said Tom Shaffer, executive vice president of global sales and marketing at MTF Biologics. “As we continue to expand the many ways we work with and serve those in plastic and reconstructive surgery, we are proud to be able to deliver LipoGrafter, a revolutionary fat grafting system, to patients and plastic surgeons around the world.”

Related Links:
MTF Biologics

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Stereotactic Ultralight System
SUSy

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.